Article Text

Download PDFPDF
OP013 Effectiveness of conventional and cooled RF in treating chronic knee pain: initial findings from the cogenius trial: interim report
  1. Amy Belba1,2,3,
  2. Thibaut Vanneste1,4,
  3. William Aerts1,2,
  4. Leander Mancel1,2,
  5. Sarah Shiba1,2,
  6. Walter Staelens1,2 and
  7. Jan Van Zundert1,4
  1. 1Anesthesia, ZOL Genk, Genk, Belgium
  2. 2Anesthesia, New York School of Regional Anesthesia (NYSORA), New York, USA
  3. 3Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium
  4. 4Anesthesiology and Pain Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands

Abstract

Please confirm that an ethics committee approval has been applied for or granted: Yes: I’m uploading the Ethics Committee Approval as a PDF file with this abstract submission

Background and Aims The COGENIUS trial aims to evaluate the cost-effectiveness and efficacy of conventional and cooled RF treatments in patients with therapy-resistant chronic knee pain due to osteoarthritis (OA) and persistent post-surgical pain (PPSP) after a total knee prosthesis.

Methods The COGENIUS trial is a multicenter double-blinded, randomized controlled trial of 2-year follow-up. After an initial run-in period, 200 patients per subgroup will be randomized to receive either conventional RF, cooled RF, or a sham procedure in a 2:2:1 ratio (Fig. 1,2). The analysis includes a comparison of the effectiveness of each RF treatment with the sham procedure and between conventional and cooled RF. The primary outcome is the Western Ontario and McMaster Universities Osteoarthritis Index score at 6 months. Knee pain, functionality, quality of life, emotional health, medication use and cost constitute secondary endpoints.

Results To date, 822 patients have been screened, of which were 220 eligible for the trial and 164 randomized across 14 centers. Of these, 63 participants belong to the OA subgroup and 101 to the PPSP subgroup. The enrollment began on 7 July 2022, with the trial projected to conclude in March 2028. Most exclusions occurred due to bilateral knee pain (128/822), refusal to participate (85/822), and chronic widespread pain (49/822). Until present 12 of the 220 patients experienced adequate improvement in pain after the run-in period.

Abstract OP013 Figure 1

The radiofrequency treatment of the genicular nerves. The ultrasound approach to target two genicular nerves: the superomedial genicular nerve (SMGN) and the superolateral genicular nerve (SLGN). The procedure to target the inferomedial genicular nerve (IMGN) is similar to the SMGN. The RF needle is marked with yellow arrows. The target point is marked with white arrows

Abstract OP013 Figure 2

Flowchart of the COGENIUS trial

Conclusions This ongoing study aims to delineate the relative effectiveness of cooled and conventional RF treatments compared to a sham procedure in patients with chronic knee pain.

  • Efectiveness
  • conventional
  • cooled
  • radiofrequency ablation
  • chronic knee pain.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.